🇺🇸 FDA
Patent

US 9056907

Human domain antibodies against components of the human insulin-like growth factor (IGF) system

granted A61KA61K2039/505A61K39/39591

Quick answer

US patent 9056907 (Human domain antibodies against components of the human insulin-like growth factor (IGF) system) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jun 11 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Jun 16 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 11 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K2039/505, A61K39/39591, A61P, A61P35/00